• No results found

Human mesenchymal stromal cells : biological characterization and clinical application

N/A
N/A
Protected

Academic year: 2021

Share "Human mesenchymal stromal cells : biological characterization and clinical application"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Human mesenchymal stromal cells : biological characterization and clinical application

Bernardo, M.E.

Citation

Bernardo, M. E. (2010, March 4). Human mesenchymal stromal cells : biological

characterization and clinical application. Retrieved from https://hdl.handle.net/1887/15034

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/15034

Note: To cite this publication please use the final published version (if applicable).

(2)

Human Mesenchymal Stromal Cells: Biological Characterization and Clinical Application

(3)

2

Colofon

About the cover:

© Rene Magritte, Ceci n’est pas une pomme, c/o Pictoright Amsterdam 2010 Collection Scheringa Museum of Realism, The Netherlands

Printed by Wöhrmann Print Service, Zutphen, The Netherlands

The research presented in this thesis have been performed, in part, in Leiden at the Departments of Hematology (Prof. R. Willemze) and Immuno- Hematology and Blood Transfusion, LUMC (Prof. W.E. Fibbe) and, in part, in Pavia at the Department of Pediatric Onco-Hematology, Fondazione IRCCS Policlinico San Matteo (Prof. F. Locatelli). This work has been carried out in collaboration with the Departments of Pediatrics, Sub- Department Immunology, Haematology, Oncology, Bone Marrow Transplantation and Autoimmune diseases, LUMC, Leiden, The Netherlands and Division of Clinical Immunology and Centre for Allogeneic Stem Cell Transplantation, Karolinska Institute, Huddinge University, Stockholm, Sweden. The study has been supported by the School of Specialization in Pediatrics, University of Pavia (Prof. G. Rondini).

© M.E. Bernardo, Leiden, the Netherlands. All rights reserved. No part of this book may be reproduced or transmitted, in any form or by any means, without the written permission of the author.

ISBN: 978-90-8570-505-5

The printing of this thesis was financially supported by Interlabo Srl, Treviglio (BG), Italy.

Address for correspondence:

Maria Ester Bernardo, Onco-ematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo. V.le Golgi, 2. 27100 Pavia, Italy. Phone: +39-0382- 502607; fax: +39-0382-501251.

E-mail: mebernardo@gmail.com

(4)

Human Mesenchymal Stromal Cells:

Biological Characterization and Clinical Application

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof. mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op donderdag 4 maart 2010

klokke 10.00 uur.

door

Maria Ester Bernardo geboren te Voghera, Italië

in 1975

(5)

4

Promotie commissie

Promotores: Prof. Dr. W.E. Fibbe

Prof. F. Locatelli (University of Pavia, Italy)

Overige Leden: Prof. Dr. R.M. Egeler Prof. Dr. A.J. Rabelink

Prof. F. Dazzi (Imperial College, London)

(6)

Ai miei genitori

(7)

6

(8)

TABLE OF CONTENTS

CHAPTER 1: GENERAL INTRODUCTION 9

Published with minor modifications in Ann N Y Acad Sci. (2009;1176:101- 117. Review)

CHAPTER 2 45

Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources.

Connect Tissue Res. 2007;48:132-140.

CHAPTER 3 65

Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.

J Cell Physiol. 2007; 211:121-130.

CHAPTER 4 97

Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

Cancer Res. 2007;67:9142-9149.

CHAPTER 5 123

Co-transplantation of ex-vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation.

Blood. 2007;110:2764-2767.

CHAPTER 6 135

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Lancet. 2008;371:1579-1586.

CHAPTER 7 159

Phenotypical/functional characterization of in vitro expanded mesenchymal

(9)

8

CHAPTER 8 185

Generation of mesenchymal stromal cells in the presence of platelet lysate:

a phenotypical and functional comparison between umbilical cord blood- and bone marrow-derived progenitors.

Haematologica. 2009;94:1649-1660. Epub 2009 Sep 22.

CHAPTER 9: GENERAL DISCUSSION 221

List of abbreviations 249

Summary in Dutch 251

Summary in English 253

Summary in Italian 255

Curriculum vitae 257

List of publications 258

Referenties

GERELATEERDE DOCUMENTEN

Nevertheless, MSCs of bone marrow origin, either fetal or adult, exhibit a higher chondrogenic potential than fetal lung and placenta derived MSCs, as demonstrated by the

Also for this set of experiments, MSCs-FCS and MSCs-PL were chosen and tested for their genomic situation; in particular four of the eight BM donors were studied at baseline

MSCs from all donors were characterized by morphology, differentiation capacity and immune phenotype at different culture time points, namely P3, P6, P9, P12, P15 and later,

1 However, both primary (defined as lack of hematologic recovery or absence of donor chimerism) and secondary (defined as loss of donor chimerism after initial engraftment) 2

Patients with steroid-resistant, severe, acute GVHD were treated with mesenchymal stem cells, derived with the European Group for Blood and Marrow Transplantation ex-vivo

MSCs from bone marrow (BM) of 7 CD-patients (median age 32 years) were expanded ex vivo in the presence of 5% platelet lysate; cells were investigated for clonogenic

We also investigated the biological/functional properties of UCB-MSCs, in comparison with PL-expanded bone marrow (BM)-MSCs. Success rate of MSC isolation from UCB was in the order

However, at present, no specific marker or combination of markers has been identified that specifically defines true MSCs and ex vivo expanded cells are currently stained with